About NYTRICX, INC.
Nytricx, Inc. is a University of Georgia spinoff company developing nitric oxide (NO)-releasing anti-microbial medical devices. The company focuses on creating safe, effective, and cutting-edge device solutions that improve treatment outcomes in critical medical applications.
Development of nitric oxide (NO)-releasing anti-microbial medical devicesCreation of safe and effective device solutions for critical medical applicationsUtilization of NORel (Nitric Oxide Release) technology with sustained activity up to 30 daysDevelopment of cyto-compatible and non-toxic medical technologies
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE | Department of Health and Human Services | $746K |
Is this your company?
Claim NYTRICX, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim NYTRICX, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.